Nan Shan Life Insurance Co. Ltd. lowered its holdings in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) by 84.2% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 7,338 shares of the semiconductor company’s stock after selling 39,237 shares during the period. Nan Shan Life Insurance Co. Ltd.’s holdings in Lam Research were worth $3,180,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in LRCX. Bayban bought a new position in shares of Lam Research during the 4th quarter worth approximately $26,000. Vermillion Wealth Management Inc. acquired a new position in shares of Lam Research during the 1st quarter valued at $26,000. Cedar Mountain Advisors LLC boosted its stake in Lam Research by 242.9% during the first quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company’s stock worth $26,000 after acquiring an additional 85 shares in the last quarter. Paladin Partners LLC bought a new position in Lam Research during the second quarter worth $26,000. Finally, Mcguire Capital Advisors Inc. acquired a new stake in Lam Research in the fourth quarter worth $27,000. 84.61% of the stock is currently owned by institutional investors.
Insider Activity at Lam Research
In other Lam Research news, Director Eric Brandt sold 54,500 shares of the firm’s stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the transaction, the director directly owned 199,205 shares in the company, valued at approximately $69,881,114. This trade represents a 21.48% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Ava Harter sold 5,000 shares of Lam Research stock in a transaction on Monday, August 31st. The stock was sold at an average price of $302.46, for a total transaction of $1,512,300.00. Following the transaction, the insider directly owned 42,462 shares in the company, valued at $12,843,056.52. This represents a 10.53% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 77,782 shares of company stock valued at $26,755,370. 0.31% of the stock is owned by insiders.
Key Stories Impacting Lam Research
- Positive Sentiment: UBS maintained a Buy rating and set a $425 price target, down from $435 but still implying substantial potential upside. The target reflects continued confidence in Lam’s semiconductor-equipment opportunity. UBS price-target article
- Positive Sentiment: Recent coverage highlights strong semiconductor demand, AI infrastructure investment and Lam’s earnings momentum. The company recently exceeded quarterly earnings and revenue expectations, while revenue increased year over year; it also raised its dividend by 27%. Dividend increase article
- Neutral Sentiment: Analysts and investor commentary remain divided: some view the recent pullback as a buying opportunity, while others caution that Lam’s valuation and exposure to China could limit near-term returns. Lam Research pullback analysis
- Negative Sentiment: A global bond selloff pushed long-term yields higher, pressuring high-multiple semiconductor stocks. Higher yields can raise corporate financing costs and reduce the present value investors assign to future growth. Semiconductor sector selloff article
- Negative Sentiment: An insider sold 5,000 shares worth approximately $1.5 million. The transaction was made under a pre-arranged Rule 10b5-1 plan, which reduces its signaling value, but it still adds to short-term selling pressure. SEC insider-sale filing
- Negative Sentiment: Crude oil’s surge and higher benchmark Treasury yields revived inflation concerns, reinforcing worries that interest rates may remain restrictive for longer and weighing on LRCX alongside other semiconductor stocks. Market selloff article
Analysts Set New Price Targets
Several equities research analysts have weighed in on the stock. Jefferies Financial Group set a $335.00 price target on shares of Lam Research and gave the company a “buy” rating in a research note on Thursday, July 30th. Oppenheimer reaffirmed an “outperform” rating and issued a $400.00 target price (up from $330.00) on shares of Lam Research in a research report on Monday, June 15th. Citigroup reaffirmed a “buy” rating and set a $450.00 price target (up from $315.00) on shares of Lam Research in a research note on Wednesday, June 17th. Needham & Company LLC reissued a “buy” rating and issued a $390.00 price objective on shares of Lam Research in a research note on Thursday, July 30th. Finally, Rothschild & Co Redburn boosted their price objective on Lam Research from $305.00 to $420.00 and gave the company a “buy” rating in a report on Wednesday, June 17th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, Lam Research has an average rating of “Moderate Buy” and an average price target of $358.97.
Check Out Our Latest Analysis on Lam Research
Lam Research Price Performance
Shares of NASDAQ LRCX opened at $290.20 on Wednesday. The stock has a market cap of $363.13 billion, a price-to-earnings ratio of 50.38, a PEG ratio of 1.20 and a beta of 1.85. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 2.63. Lam Research Corporation has a fifty-two week low of $94.11 and a fifty-two week high of $438.50. The firm’s 50-day simple moving average is $326.64 and its 200 day simple moving average is $290.48.
Lam Research (NASDAQ:LRCX – Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, topping analysts’ consensus estimates of $1.69 by $0.13. The firm had revenue of $6.72 billion during the quarter, compared to analyst estimates of $6.66 billion. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The company’s revenue for the quarter was up 30.0% on a year-over-year basis. During the same period in the previous year, the company posted $1.33 EPS. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, research analysts anticipate that Lam Research Corporation will post 9.33 earnings per share for the current fiscal year.
Lam Research Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 14th. Investors of record on Wednesday, September 23rd will be given a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Wednesday, September 23rd. This is an increase from Lam Research’s previous quarterly dividend of $0.26. Lam Research’s payout ratio is currently 18.06%.
Lam Research Company Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Recommended Stories
- Five stocks we like better than Lam Research
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
